Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,533,029
+$56,005 QoQ
Shares Held
6,995
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,146
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERIDIAN INVESTMENT COUNSEL INC. holds $23,634,584 across 8 Drug Manufacturers - General names. AMGN ranks #5 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,506 | $6,418,329 | |
| 2 | JNJ |
Johnson & Johnson
|
22,704 | $5,766,134 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
31,450 | $3,973,393 | |
| 4 | NVO |
Novo Nordisk A S
|
63,091 | $3,024,582 | |
| 5 | AMGN |
Amgen Inc
This page
|
6,995 | $2,533,029 | |
| 6 | PFE |
Pfizer Inc
|
50,187 | $1,208,502 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,923 | $504,105 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,584 | $206,510 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,533,029 | 6,995 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,477,024 | 7,040 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,304,262 | 7,040 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,986,688 | 7,040 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,965,638 | 7,040 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,108,258 | 6,767 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,763,750 | 6,767 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,180,395 | 6,767 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,208,084 | 7,067 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,009,289 | 7,067 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,059,343 | 7,150 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,921,634 | 7,150 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,609,645 | 7,250 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,778,554 | 7,357 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,932,242 | 7,357 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,708,982 | 7,582 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,911,608 | 7,857 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,924,161 | 7,957 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,790,086 | 7,957 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,728,419 | 8,128 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,981,200 | 8,128 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $1,849,404 | 7,433 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,708,995 | 7,433 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,889,171 | 7,433 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,871,077 | 7,933 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,608,257 | 7,933 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||